Model for vaccine design by prediction of B-epitopes of IEDB given perturbations in peptide sequence, in vivo process, experimental techniques, and source or host organisms

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  González Díaz, Humberto ^a,b   Pérez Montoto, Lázaro G ^c   Ubeira, Florencio M ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B EPITOPE; EPITOPE; UNCLASSIFIED DRUG; VACCINE; PEPTIDE; PROTEIN BINDING;

ALMOND; AMERICAN MINK; AMINO ACID SEQUENCE; ANAPLASMA MARGINALE; ANAS PLATYRHYNCHOS; ANDES VIRUS; ANDROCTONUS AUSTRALIS; AOTUS; AOTUS GRISEIMEMBRA; AOTUS LEMURINUS; AOTUS NANCYMAAE; ARTICLE; ASPERGILLUS FUMIGATUS; BABESIA EQUI; BACILLUS ANTHRACIS; BORDETELLA PERTUSSIS; BORRELIA BURGDORFERI; BOVINE LEUKEMIA VIRUS; BOVINE PAPILLOMAVIRUS; BUCKWHEAT; CALLITHRIX; CALLITHRIX PYGMAEA; CANDIDA ALBICANS; CANINE PARVOVIRUS; CANIS LUPUS; CASHEW NUT; CAVIA PORCELLUS; CHINCHILLA; CHINCHILLA LANIGERA; CHINESE HAMSTER; CHIRONOMUS THUMMI; CHLAMYDIA PNEUMONIAE; CHLAMYDIA TRACHOMATIS; CHLOROCEBUS AETHIOPS; CLOSTRIDIUM BOTULINUM; CONUS GEOGRAPHUS; CRICETULUS MIGRATORIUS; DENGUE VIRUS 2; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DIAGNOSTIC ACCURACY; DOG; DOMESTIC CAT; DOMESTIC GOAT; DOMESTIC HORSE; DOMESTIC SHEEP; DROMEDARY; DRUG DESIGN; DUCK HEPATITIS B; ENTEROVIRUS; EQUINE INFECTIOUS VIRUS; ESCHERICHIA COLI; EUROPEAN SEA BASS; EXPERIMENTAL HOST; EXPERIMENTATION; FASCIOLA HEPATICA; FOOT AND MOUTH DISEASE VIRUS; GALLUS GALLUS; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; HEPATITIS VIRUS; HEVEA BRASILIENSIS; HUMAN; HUMAN ADENOVIRUS C; HUMAN COXSACKIEVIRUS; HUMAN ENTEROVIRUS; HUMAN HEPATITIS VIRUS; HUMAN HERPESVIRUS; HUMAN POLIOVIRUS; HUMAN RESPIRATORY VIRUS; HUMAN T LYMPHOTROPIC VIRUS; IN VIVO STUDY; INFLUENZA A VIRUS; JAPANESE CEDAR; JUNIPERUS ASHEI; LEISHMANIA INFANTUM; MACACA CYCLOPIS; MACACA FASCICULARIS; MACACA FUSCATA; MACCULLOCHELLA MACQUARIENSIS; MARKOV CHAIN; MATHEMATICAL MODEL; MEASLES VIRUS; MICROORGANISM; MURINE HEPATITIS VIRUS; MUS MUSCULUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA HYOPNEUMONIAE; MYODES GLAREOLUS; NEISSERIA MENINGITIDIS; NONHUMAN; OLIVE TREE; ONCORHYNCHUS MYKISS; ONCORHYNCHUS TSHAWYTSCHA; ORIENTIA TSUTSUGAMUSHI; ORYCTOLAGUS CUNICULUS; PAN TROGLODYTES; PAPIO CYNOCEPHALUS; PARECHOVIRUS; PEANUT; PIG; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POA PRATENSIS; PORCINE ENDOGENOUS; PORCINE REPRODUCTIVE; PORPHYROMONAS GINGIVALIS; PREDICTION; PROTEIN DETERMINATION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; PUUMALA VIRUS; QUANTITATIVE STRUCTURE PROPERTY RELATION; RATTUS NORVEGICUS; RATTUS RATTUS; RENIBACTERIUM SALMONINARUM; RESPIRATORY VIRUS; RHESUS MONKEY; RICINUS COMMUNIS; ROSEOLOVIRUS; SAIMIRI SCIUREUS; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SHIGELLA FLEXNERI; SOYBEAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PYOGENES; SYRIAN HAMSTER; TAURINE CATTLE; THEILERIA PARVA; TITYUS SERRULATUS; TORPEDO CALIFORNICA; TREPONEMA PALLIDUM; TRICHOSURUS VULPECULA; TRITICUM AESTIVUM; TRYPANOSOMA CRUZI; VIBRIO CHOLERAE; VIRUS INFECTIVITY; WART VIRUS; WOODCHUCK; ZEBU; ANIMAL; BACTERIUM; BIOLOGICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; FUNGUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PLANT; PROTEIN DATABASE; VIRUS;

ANIMALS; BACTERIA; COMPUTER SIMULATION; DATABASES, PROTEIN; DRUG DESIGN; EPITOPES; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES; PLANTS; PROTEIN BINDING; VACCINES; VIRUSES;

EID: 84921905536     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/768515     Document Type: Article

References (65)

1. B. Peters, J. Sidney, P. Bourne et al., "The design and implementation of the immune epitope database and analysis resource," Immunogenetics, vol. 57, no. 5, pp. 326-336, 2005.
2. B. Peters, J. Sidney, P. Bourne et al., "The immune epitope database and analysis resource: from vision to blueprint," PLoS Biology, vol. 3, no. 3, p. e91, 2005.
3. P. Wang, A.A. Morgan, Q. Zhang, A. Sette, and B. Peters, "Automating document classification for the Immune Epitope Database," BMC Bioinformatics, vol. 8, article 269, 2007.
4. A. Sette, "The immune epitope database and analysis resource: from vision to blueprint," Genome Informatics, vol. 15, no. 2, p. 299, 2004.
5. N. Salimi, W. Fleri, B. Peters, and A. Sette, "The immune epitope database: a historical retrospective of the first decade," Immunology, vol. 137, no. 2, pp. 117-123, 2012.
6. Y. Kim, A. Sette, and B. Peters, "Applications for T-cell epitope queries and tools in the Immune EpitopeDatabase and Analysis Resource," Journal of Immunological Methods, vol. 374, no. 1-2, pp. 62-69, 2011.
7. Y. Kim, J. Ponomarenko, Z. Zhu, D. Tamang et al., "Immune epitope database analysis resource," Nucleic Acids Research, pp. W525-W530, 2012.
8. A. M. Helguera, R. D. Combes, M. P. Gonzalez, and M. N. D. S. Cordeiro, "Applications of 2D descriptors in drug design: a DRAGON tale," Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1628-1655, 2008.
9. G. M. Casañola-Martín, Y.Marrero-Ponce, M. T. H. Khan et al., "Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays," The European Journal ofMedicinal Chemistry, vol. 42, no. 11-12, pp. 1370- 1381, 2007.
10. I. V. Tetko, J. Gasteiger, R. Todeschini et al., "Virtual computational chemistry laboratory-design and description," Journal of Computer-AidedMolecular Design, vol. 19, no. 6, pp. 453-463, 2005.
11. A. R. Katritzky, A. Oliferenko, A. Lomaka, and M. Karelson, "Six-membered cyclic ureas as HIV-1 protease inhibitors: a QSAR study based on CODESSA PRO approach," Bioorganic and Medicinal Chemistry Letters, vol. 12, no. 23, pp. 3453-3457, 2002.
12. A. R. Katritzky, S. Perumal, R. Petrukhin, and E. Kleinpeter, "CODESSA-based theoreticalQSPRmodel for hydantoin HPLC-RT lipophilicities," Journal of Chemical Information and Computer Sciences, vol. 41, no. 3, pp. 569-574, 2001.
13. S. Vilar, G. Cozza, and S. Moro, "Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery," Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1555-1572, 2008.
14. G. Marzaro, A. Chilin, A. Guiotto et al., "Using the TOPSMODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors," The European Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 2185-2192, 2011.
15. S. Vilar, E. Estrada, E. Uriarte, L. Santana, and Y.Gutierrez, "In silico studies toward the discovery of new anti-HIV Nucleoside compounds through the use of tops-mode and 2D/3D connectivity indices. 2. Purine derivatives," Journal of Chemical Information and Modeling, vol. 45, no. 2, pp. 502-514, 2005.
16. E. Estrada, J. A. Quincoces, and G. Patlewicz, "Creating molecular diversity fromantioxidants in Brazilian propolis. combination of TOPS-MODE QSAR and virtual structure generation," Molecular Diversity, vol. 8, no. 1, pp. 21-33, 2004.
17. E. Estrada and H.González, "What are the limits of applicability for graph theoretic descriptors in QSPR/QSAR? modeling dipole moments of aromatic compounds with TOPS-MODE descriptors," Journal of Chemical Information and Computer Sciences, vol. 43, no. 1, pp. 75-84, 2003.
18. Y. Marrero-Ponce, J. A. Castillo-Garit, E. Olazabal et al., "Tomocomd- Cardd, a novel approach for computer-aided "rational" drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds," Journal of Computer- Aided Molecular Design, vol. 18, no. 10, pp. 615-634, 2004.
19. Y. Marrero Ponce, R. MedinaMarrero, E. A. Castro et al., "Protein quadratic indices of the "macromolecular pseudograph's - carbon atom adjacency matrix". 1. prediction of arc repressor alanine-mutant's stability,"Molecules, vol. 9, no. 12, pp. 1124-1147, 2004.
20. H. González-Díaz, F. Prado-Prado, and F. M. Ubeira, "Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach," Current Topics inMedicinal Chemistry, vol. 8, no. 18, pp. 1676-1690, 2008.
21. R. García-Domenech, J. Gálvez, J. V. de Julián-Ortiz, and L. Pogliani, "Some newtrends in chemical graph theory," Chemical Reviews, vol. 108, no. 3, pp. 1127-1169, 2008.
22. E. Estrada and E. Uriarte, "Recent advances on the role of topological indices in drug discovery research," Current Medicinal Chemistry, vol. 8, no. 13, pp. 1573-1588, 2001.
23. R. Todeschini and V. Consonni, Handbook ofMolecularDescriptors, Wiley-VCH,Weinheim, Germany, 2008.
24. E. Estrada, E. J. Delgado, J. B. Alderete, and G. A. Jaña, "Quantum- connectivity descriptors inmodeling solubility of environmentally important organic compounds," Journal of Computational Chemistry, vol. 25, no. 14, pp. 1787-1796, 2004.
25. E.Besalu, X. Girones, L. Amat, andR. Carbo-Dorca, "Molecular quantum similarity and the fundamentals of QSAR," Accounts of Chemical Research, vol. 35, no. 5, pp. 289-295, 2002.
26. D. A. Rincón, M. N. D. S. Cordeiro, and R. A. Mosquera, "On the electronic structure of cocaine and its metabolites," Journal of Physical Chemistry A, vol. 113, no. 50, pp. 13937-13942, 2009.
27. M. Mandado, M. J. González-Moa, and R. A. Mosquera, "Chemical graph theory and n-center electron delocalization indices: a study on polycyclic aromatic hydrocarbons," Journal of Computational Chemistry, vol. 28, no. 10, pp. 1625-1633, 2007.
28. T.Hill and P. Lewicki, STATISTICS:Methods andApplications:A Comprehensive Reference for Science, Industry and DataMining, StatSoft, Tulsa,Okla, USA, 2006.
29. E. Frank,M.Hall, L. Trigg, G. Holmes, and I. H. Witten, "Data mining in bioinformatics using Weka," Bioinformatics, vol. 20, no. 15, pp. 2479-2481, 2004.
30. G. Patlewicz, N. Ball, E. D. Booth, E. Hulzebos, E. Zvinavashe, and C. Hennes, "Use of category approaches, read-across and (Q)SAR: general considerations," Regulatory Toxicology and Pharmacology, vol. 67, no. 1, pp. 1-12, 2013.
31. D. W. Roberts and G. Y. Patlewicz, "Updating the skin sensitization in vitro data assessment paradigm in 2009-a chemistry and QSAR perspective," Journal of Applied Toxicology, vol. 30, no. 3, pp. 286-288, 2010.
32. D.W. Roberts and G. Y. Patlewicz, "Nonanimal alternatives for skin sensitization: letter to the editor," Toxicological Sciences, vol. 106, no. 2, pp. 572-574, 2008.
33. E. Estrada, G. Patlewicz, and Y. Gutierrez, "From knowledge generation to knowledge archive. a general strategy using TOPS-MODE with DEREK to formulate new alerts for skin sensitization," Journal of Chemical Information and Computer Sciences, vol. 44, no. 2, pp. 688-698, 2004.
34. G. F. Gerberick, C. A. Ryan, P. S. Kern et al., "A chemical dataset for evaluation of alternative approaches to skin-sensitization testing," Contact Dermatitis, vol. 50, no. 5, pp. 274-288, 2004.
35. G. Y. Patlewicz,D. A. Basketter, C. K. Smith Pease et al., "Further evaluation of quantitative structure-activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens," Contact Dermatitis, vol. 50, no. 2, pp. 91-97, 2004.
36. E. Estrada, G. Patlewicz, M. Chamberlain, D. Basketter, and S. Larbey, "Computer-aided knowledge generation for understanding skin sensitization mechanisms: the TOPS-MODE approach," Chemical Research in Toxicology, vol. 16, no. 10, pp. 1226-1235, 2003.
37. G. Patlewicz, R. Rodford, and J. D.Walker, "Quantitative structure- activity relationships for predicting skin and eye irritation," Environmental Toxicology and Chemistry, vol. 22, no. 8, pp. 1862-1869, 2003.
38. G. Y. Patlewicz, R. A. Rodford, G. Ellis, and M. D. Barratt, "A QSAR model for the eye irritation of cationic surfactants," Toxicology In Vitro, vol. 14, no. 1, pp. 79-84, 2000.
39. E. Tenorio-Borroto, C. G. Penuelas Rivas, J. C. Vasquez Chagoyan, N. Castanedo, F. J. Prado-Prado, and X. Garcia- Mera, "ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen," Bioorganic & Medicinal Chemistry, vol. 20, no. 20, pp. 6181-6194, 2012.
40. D. R. Flower, H. McSparron, M. J. Blythe et al., "Computational vaccinology: quantitative approaches," Novartis Foundation Symposium, vol. 254, pp. 102-120, 2003.
41. I. A. Doytchinova, P. Guan, and D. R. Flower, "Quantitative structure-activity relationships and the prediction of MHC supermotifs," Methods, vol. 34, no. 4, pp. 444-453, 2004.
42. Y. Xiao and M. R. Segal, "Prediction of genomewide conserved epitope profiles of HIV-1: classifier choice and peptide representation," Statistical Applications in Genetics and Molecular Biology, vol. 4, no. 1, article 25, 2005.
43. T. Fagerberg, V. Zoete, S. Viatte, P. Baumgaertner, P.M. Alves, P. Romero et al., "Prediction of cross-recognition of peptide-HLA A2 by melan-a-specific cytotoxic T lymphocytes using threedimensional quantitative structure-activity relationships," PLoS ONE, vol. 8, no. 7,Article ID e65590, 2013.
44. D. Barh, A. N. Misra, A. Kumar, andA.Vasco, "Anovel strategy of epitope design in Neisseria gonorrhoeae," Bioinformation, vol. 5, no. 2, pp. 77-82, 2010.
45. J. Bi, R. Song, H. Yang et al., "Stepwise identification of HLAA ∗0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a steprank scheme," Biopolymers, vol. 96, no. 3, pp. 328-339, 2011.
46. R.D. Bremel and E. J. Homan, "An integrated approach to epitope analysis II: a system for proteomic-scale prediction of immunological characteristics," Immunome Research, vol. 6, no. 1, article 8, 2010.
47. C. M. Diez-Rivero, B. Chenlo, P. Zuluaga, and P. A. Reche, "Quantitative modeling of peptide binding to TAP using support vector machine," Proteins, vol. 78, no. 1, pp. 63-72, 2010.
48. E. Martínez-Naves, E. M. Lafuente, and P. A. Reche, "Recognition of the ligand-type specificity of classical and non-classical MHC I proteins," FEBS Letters, vol. 585, no. 21, pp. 3478-3484, 2011.
49. M. Bhasin, E. L. Reinherz, and P. A. Reche, "Recognition and classification of histones using support vectormachine," Journal of Computational Biology, vol. 13, no. 1, pp. 102-112, 2006.
50. P. A. Reche and E. L. Reinherz, "PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands," Nucleic Acids Research, vol. 33, no. 2, pp. W138-W142, 2005.
51. E. M. Lafuente and P. A. Reche, "Prediction of MHC-peptide binding: a systematic and comprehensive overview," Current Pharmaceutical Design, vol. 15, no. 28, pp. 3209-3220, 2009.
52. A. Gaulton, L. J. Bellis, A. P. Bento et al. et al., "A large-scale bioactivity database for drug discovery," Nucleic Acids Research, pp. D1100-D1107, 2012.
53. W. H. Cropper, Great Physicists: The Life and Times of Leading Physicists from Galileo to Hawking, Oxford University Press, New York, NY, USA, 2004.
54. E. L. Bouzarth, A. Brooks, R. Camassa et al., "Epicyclic orbits in a viscous fluid about a precessing rod: theory and experiments at the micro-and macro-scales," Physical Review E, vol. 76, no. 1, part 2, Article ID 016313, 2007.
55. M. Laberge, "Intrinsic protein electric fields: basic non-covalent interactions and relationship to protein-induced Stark effects," Biochimica et BiophysicaActa, vol. 1386,no. 2, pp. 305-330, 1998.
56. F. M. Fernandez and J. A.Morales, "Perturbation theorywithout wave functions for the Zeeman effect in hydrogen," Physical Review A, vol. 46, no. 1, pp. 318-326, 1992.
57. B. D. Marshall and W. G. Chapman, "Thermodynamic perturbation theory for associating fluids with small bond angles: effects of steric hindrance, ring formation, and double bonding," Physical Reiew E, vol. 87, no. 5, Article ID052307, 12 pages, 2013.
58. H. Gonzalez-Diaz, S. Arrasate, A. Gomez-San Juan et al., "New theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry," Current Topics in Medicinal Chemistry, 2013.
59. H. Gonzalez-Diaz, S. Arrasate, N. Sotomayor et al., "MIANN models in medicinal, physical and organic chemistry," Current Topics in Medicinal Chemistry, vol. 13, no. 5, pp. 619-641, 2013.
60. G. E. P. Box and G. M. Jenkins, Time Series Analysis: Forecasting and Control, Holden-Day, San Francisco, Calif, USA, 1970.
61. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, "Unified multi-target approach for the rational in silico design of anti-bladder cancer agents," Anti-Cancer Agents in Medicial Chemistry, vol. 13, no. 5, pp. 791-800, 2013.
62. A. Speck-Planche, V. V. Kleandrova, andM. N. Cordeiro, "New insights toward the discovery of antibacterial agents: multitasking QSBER model for the simultaneous prediction of antituberculosis activity and toxicological profiles of drugs," The European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 812-818, 2013.
63. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, "Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors," Current Alzheimer Research, vol. 10, no. 2, pp. 117-124, 2013.
64. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. Cordeiro, "In silico discovery and virtual screening of multitarget inhibitors for proteins in Mycobacterium tuberculosis," Combinatorial Chemistry & HighThroughput Screening, vol. 15, no. 8, pp. 666-673, 2012.
65. A. Speck-Planche, V. V. Kleandrova, F. Luan, and M. N. D. S. Cordeiro, "Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of antibreast cancer agents," The European Journal of Pharmaceutical Sciences, vol. 47, no. 1, pp. 273-279, 2012.